Post-Filter Hematocrit

Recruiting N/A Interventional Study
Continuous Renal Replacement Therapy Renal Failure Hemofilter Clotting
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
20 (estimated)
Sponsor
Gwyndolyn M. Radford · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Filter clotting is a major complication of continuous renal replacement therapy (CRRT), resulting in blood loss, reduced treatment efficacy, and increased cost. One modifiable factor associated with filter clotting is filtration fraction (FF), or the proportion of plasma water being removed from the blood over the course of the filter. In convention, a cutoff of FF\<20-30% has been used to prevent…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * patients initiated on CRRT age equal than or greater to 18 years of age Exclusion Criteria: * patients on ECMO
Contacts

Gwyndolyn M Radford, MD

7858179620

gradford@uiowa.edu

CONTACT

Benjamin R Griffin, MD

5073631404

benjamin-griffin@uiowa.edu

CONTACT